NEW YORK (GenomeWeb) – Roche said today that it plans to immediately initiate screening of blood samples with its Cobas Babesia test under an investigational new drug application protocol, and it is working with designated study sites in the US to commence testing.

The qualitative in vitro nucleic acid screening test performs direct detection of Babesia DNA and RNA in whole blood specimens from human blood donors.

To read the full story....

Register for Free.

...and receive Daily News bulletins.

Already have an account?
Login Now.